Basal biomarkers Nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: samples from the phase III SBG0102 clinical trial

This article is protected by copyright. All rights reserved.

Source: International Journal of Cancer - November 9, 2018 Category: Cancer & Oncology Authors: Karama Asleh, Stina Lyck Carstensen, Charlotte L. Tykj ær Jørgensen, Samantha Burugu, Dongxia Gao, Jennifer R. Won, Maj‐Britt Jensen, Eva Balslev, Anne‐Vibeke Lænkholm, Dorte L. Nielsen, Bent Ejlertsen, Torsten O. Nielsen Tags: Research Article Source Type: research